The good news is that scientists found ways to protect Fas Ligand from plasmin. By blocking plasmin or making Fas Ligand stronger, the immune system can once again kill cancer cells. This opens up new ideas for improving cancer treatments by combining them with plasmin-blocking drugs or special antibodies.
Friday
4 July 2025
4 July 2025
